Antiviral Distribution



In partnership with the Center for Disease Control and Prevention (CDC) and the National Association of County and City Health Officials (NACCHO), ASTHO is exploring alternative approaches to antiviral management and distribution during a public health emergency. During the 2009/10 H1N1 influenza response federal, state, and local health agencies encountered a number of issues with antiviral management and distribution.

CDC, ASTHO, and NACCHO will examine the current system and approaches used for antiviral management and distribution during H1N1, identify lessons learned, and explore options for improvements for distribution, dispensing, and tracking of antivirals - including leveraging the private sector for antiviral distribution and dispensing. The goal of this multi-year project is to improve the availability of antivirals (and potentially other countermeasures) for timely dispensing during a public health emergency.

ASTHO Resources

Managing Antiviral Medication during the 2009 H1N1 Influenza Pandemic: State and Local Public Health Department Responsibilities

Public Health and Antiviral Distribution and Dispensing: Enhancing Influenza Pandemic Response

Antiviral Distribution and Dispensing: A Review of Legal and Policy Issues

Antiviral Distribution and Dispensing: Frequently Asked Questions

NACCHO Antiviral Distribution and Dispensing Project

ASTHO Antiviral Advisory Committee

To provide guidance, direction, and technical expertise for this project, ASTHO convened the ASTHO Antiviral Advisory Committee. The committee is comprised of current and former State Health Officials, Deputy Health Officials, Preparedness Directors, SNS Coordinators, and State Epidemiologists. The committee will provide expert input into various project components, review pertinent information, and make recommendations on proposed alternative approaches. The committee will participate in this project as a group of valued stakeholders as a representative voice for state public health.

View the ASTHO Antiviral Advisory Committee membership.


  • James Blumenstock, MA, Chief Program Officer, Public Health Practice
  • Ericka McGowan, MS, Director, Infectious Disease Preparedness
  • Heather Misner, MPP, Director, Preparedness & Clinical Outreach
  • Kathy Talkington, MPAff, Senior Director, Immunization and Infectious Disease